Why the study?
Does intraperitoneal inoculation with the DA strain of Theiler's murine encephalomyelitis virus induce cardiac and skeletal muscle disease in mice?
Does intraperitoneal inoculation with the DA strain of Theiler's murine encephalomyelitis virus induce cardiac and skeletal muscle disease in mice?
The DA strain of Theiler's murine encephalomyelitis virus induces chronic myositis and focal myocarditis in mice, providing a model for virus-induced chronic myositis and human inflammatory myopathies.
Provides a murine model of virus-induced chronic myositis with focal myocarditis; leaves open translation to human inflammatory myopathies.
The DA strain of Theiler's murine encephalomyelitis virus, a member of the cardiovirus genus of picornaviruses, induces a restricted and persistent infection associated with a demyelinating process following intracerebral inoculation of mice; both virus infection and the immune response are believed to contribute to the late white matter disease. We now report that intraperitoneal inoculation with DA produces an acute myositis that progresses to a chronic inflammatory muscle disease in CD-1 mice as well as several inbred mouse strains. Some mouse strains also develop central nervous system white matter disease and a focal myocarditis. Infectious virus in skeletal muscle falls to undetectable levels 3 weeks postinoculation (p.i.), although viral genome persists for at least 12 weeks p.i., the longest period of observation. Severe combined immunodeficient animals have evidence of muscle pathology as long as 5 weeks p.i., suggesting that DA virus is capable of inducing chronic muscle disease in the absence of an immune response. The presence in immunocompetent mice, however, of prominent muscle inflammation in the absence of infectious virus suggests that the immune system also contributes to the pathology. T lymphocytes are the predominant cell type infiltrating the skeletal muscle during the chronic disease. This murine model may further our understanding of virus-induced chronic myositis and help to clarify the pathogenesis of human inflammatory myopathies.
No takes yet. Share an insight, caveat, or question.
Gómez et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: